SHANA STANDARD: Open Payments
NPI 1417977562 · SAVANNAH, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,661 in 93 payments from 24 companies in 2025. Trend: 2023 $1,653 · 2024 $1,645 · 2025 $1,661
Food & beverage: $1,661
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 11 | $213 |
| AstraZeneca Pharmaceuticals LP | 9 | $155 |
| Novo Nordisk Inc | 11 | $148 |
| Bayer Healthcare Pharmaceuticals Inc. | 9 | $143 |
| Astellas Pharma US Inc | 5 | $107 |
| Lundbeck LLC | 5 | $102 |
| Dexcom, Inc. | 5 | $86 |
| PFIZER INC. | 4 | $83 |
| Corcept Therapeutics | 3 | $68 |
| GlaxoSmithKline, LLC. | 4 | $68 |
Products named: Kerendia, REXULTI, JARDIANCE, Veozah, MOUNJARO, Dexcom G6 Transmitter, AIRSUPRA, Korlym.
Industry payments across GA — which companies pay providers there.
